- Trials with a EudraCT protocol (1,010)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (49)
1,010 result(s) found for: Relief.
Displaying page 1 of 51.
EudraCT Number: 2010-021406-38 | Sponsor Protocol Number: Finaledition | Start Date*: 2012-08-28 |
Sponsor Name:Mariefreds Vårdcentral | ||
Full Title: EMLA CREAM AS PAIN RELIEF DURING PNEUMOCOCCAL VACCINATION | ||
Medical condition: Pain relief with Emla cream during Pneumococcal vaccination. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003257-29 | Sponsor Protocol Number: 030(Z)WO19176 | Start Date*: 2020-02-25 |
Sponsor Name:Angelini S.p.A. | ||
Full Title: Phase IV study comparing the efficacy and safety of Benzydamine hydrochloride 0,3% oromucosal spray and Benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat. | ||
Medical condition: acute sore throat | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002339-24 | Sponsor Protocol Number: NA | Start Date*: 2012-05-25 |
Sponsor Name:Barts and the London NHS Trust | ||
Full Title: Open label, single-centre study to evaluate the efficacy of the bradykinin (BK) B2 receptor antagonist, Icatibant, in the relief of symptoms resulting from moderate to severe angioedema unresponsiv... | ||
Medical condition: Idiopathic Angioedema | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001170-92 | Sponsor Protocol Number: 16787 | Start Date*: 2007-09-12 |
Sponsor Name:Erasmus MC | ||
Full Title: Dexamethasone for postoperative pain relief following tonsillectomy in children | ||
Medical condition: (Adeno)Tonsillectomy and Pain | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002220-37 | Sponsor Protocol Number: UP-CLI-2020-001 | Start Date*: 2021-02-24 |
Sponsor Name:UNITHER Pharmaceuticals | ||
Full Title: Comparison of the analgesic effect of a new paracetamol formulation (paracetamol UNIFLASH) for buccal use and two different doses of an oral paracetamol form controlled versus placebo in patients s... | ||
Medical condition: Symptomatic short-term treatment of moderate pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006762-29 | Sponsor Protocol Number: NL0804 | Start Date*: 2009-01-16 | |||||||||||
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | |||||||||||||
Full Title: A double-blind, randomised, crossover, single dose, single centre, study examining the analgesic efficacy and tolerability of fixed-dose combinations of ibuprofen 200mg and acetaminophen 500mg, ibu... | |||||||||||||
Medical condition: Primary Dysmenorrhoea | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004264-23 | Sponsor Protocol Number: GL61-001 | Start Date*: 2006-01-31 |
Sponsor Name:Gastrotech Pharma A/S | ||
Full Title: A randomized, double-blind, placebo controlled, cross-over, multi-center study to assess the effect of the GLP-1 analogue LY307161 in patients suffering from Irritable Bowel Disease | ||
Medical condition: Irritable Bowel Disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004176-35 | Sponsor Protocol Number: AH-09-10 | Start Date*: 2015-06-26 |
Sponsor Name:Pfizer | ||
Full Title: Evaluation Of The Efficacy Of A Novel Ibuprofen Formulation In The Treatment Of Post Surgical Dental Pain: Study I | ||
Medical condition: Post Surgical Dental Pain | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-000493-23 | Sponsor Protocol Number: A2260335 | Start Date*: 2007-04-05 |
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||
Full Title: A Comparison of Two Analgesic Products for the Treatment of Headache | ||
Medical condition: Treatment of tension headache | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005240-33 | Sponsor Protocol Number: MENTH001 | Start Date*: 2016-02-26 | |||||||||||
Sponsor Name:The Mentholatum Company Ltd | |||||||||||||
Full Title: A single centre, randomised, single-blind, parallel group single dose study to compare the speed of onset of ibuprofen gel, ibuprofen gel with levomenthol, and diclofenac gel in the relief of pain ... | |||||||||||||
Medical condition: Pain of strains, sprains and sports injuries | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004886-15 | Sponsor Protocol Number: MTA:CT4-09-18--Sponsor:18I-Fsg08 | Start Date*: 2019-05-17 | |||||||||||
Sponsor Name:IBSA INSTITUT BIOCHIMIQUE SA | |||||||||||||
Full Title: Evaluation of Treatment Satisfaction, Effectiveness and Tolerability in Subjects treated with Low-dose Diclofenac Epolamine Soft Capsules for Acute, Mild or Moderate Musculoskeletal Pain | |||||||||||||
Medical condition: Patients with acute, mild or moderate musculoskeletal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004977-42 | Sponsor Protocol Number: CB-01-11/28 | Start Date*: 2017-11-10 | |||||||||||
Sponsor Name:Cosmo Technologies Ltd. | |||||||||||||
Full Title: A Phase II, multicentre, randomised, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX® 600 mg tablets administered three or two times daily to pat... | |||||||||||||
Medical condition: Diarrhoea-predominant irritable bowel syndrome (IBS-D) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) ES (Temporarily Halted) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001556-12 | Sponsor Protocol Number: RD-5103-024-05 | Start Date*: 2006-08-17 |
Sponsor Name:Derby Hospitals NHS Foundation Trust | ||
Full Title: Hamstrings Graft Donor Site Infiltration with Bupivacaine for Pain Relief after Arthroscopically Assisted Anterior Cruciate Ligament Reconstruction | ||
Medical condition: Anterior Cruciate Ligament Reconstruction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001519-39 | Sponsor Protocol Number: 2008-02-12-1 | Start Date*: Information not available in EudraCT |
Sponsor Name:Biologiske Stasjon Drøbak | ||
Full Title: Efficiency of a jellyfish sting inhibitor sun lotion and protocols for jellyfish sting pain relief | ||
Medical condition: The degree of pain reduction in test subjects using a specific jellyfish (cnidaria) sting inhibitor and repellent lotion, compared to control subjects being protected by a normal water repellent su... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019414-24 | Sponsor Protocol Number: GA0921 | Start Date*: 2010-07-09 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets... | ||
Medical condition: Investigating efficacy in terms of heatburn relief in healthy subjects following a refluxogenic meal. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005263-29 | Sponsor Protocol Number: 25-01 | Start Date*: 2006-01-31 |
Sponsor Name:Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research) [...] | ||
Full Title: Multiple Sclerosis and Extract of Cannabis (MUSEC): A randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sa... | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005257-22 | Sponsor Protocol Number: RG_12-151 | Start Date*: 2013-07-12 |
Sponsor Name:University of Birmingham | ||
Full Title: Remifentanil intravenous patient controlled analgesia (PCA) versus intramuscular pethidine for pain relief in labour: a randomised controlled trial | ||
Medical condition: Childbirth | ||
Disease: | ||
Population Age: | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015619-42 | Sponsor Protocol Number: XPF-001-202 | Start Date*: 2010-02-09 | |||||||||||
Sponsor Name:Xenon Pharmaceuticals Inc. | |||||||||||||
Full Title: Phase 2a, Single-Blind, Placebo-Controlled, 3-Period, 2-Treatment, Crossover Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Oral Doses of XPF-001 in Patients with Inherited... | |||||||||||||
Medical condition: Inherited erythromelalgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000503-16 | Sponsor Protocol Number: P170903J | Start Date*: 2021-02-12 |
Sponsor Name:Assistance Publique- Hôpiaux de Paris | ||
Full Title: Randomized, double-blind, single-centre, randomized study evaluating the efficacy of CLORazepate dipotassium in the treatment of migraine crisis in the emergency department. | ||
Medical condition: Adults of full age, excluding pregnant or breastfeeding women, admitted to the CUC for headaches | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002657-60 | Sponsor Protocol Number: STO-010 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Klinikum der Universität | |||||||||||||
Full Title: THE EFFECT OF NEU-P11 ON SYMPTOMS IN PATIENTS WITH D-IBS | |||||||||||||
Medical condition: Irritable Bowel Syndrome (IBS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
